HugoScore hugoscore.org

Full review

Neatly Health CAIHL draft report

Evidence-linked HugoScore draft report for a health AI tool that affects patients.

Agency checklist · October 30, 2026

Mixed 7 of 12 yes

Document-based draft. Independent confirmation is incomplete. Hugo has not personally verified this service.

Assessed function: Patient-initiated recording, summaries and health questions, with separate cohort-insight commercialization and optional third-party opportunities.

A no can mean missing documentation or institution-dependent control; it does not by itself establish harmful behavior. These categories are not clinical safety or product-quality ratings.

  • Public documents do not establish actual product behavior.
  • The independent review screened rules and selected evidence; it did not replicate all twelve answers for this tool.
See all twelve answers and their evidence
QuestionAnswerEvidence / reviewSource and reasoning
1. Told it is AIYesdocumented
Not independently replicated
neatly provides an AI-powered health companion to help you understand your care. Source

Terms section 2. Privacy section 7 describes what 'Our AI' does.

2. Operator and model maker namedNonot-documented
Not independently replicated
We use trusted service providers for hosting, AI processing, and analytics. Source

Neatly Health, Inc. is named. No AI model maker is named in the Privacy Policy, Terms, FAQ, About or App Store listing.

3. Patient chooses to use itYesdocumented
Not independently replicated
Conversation recordings (doctor-patient visits you choose to record). Source

Patient downloads and starts recording. Optional third-party 'opportunities' are opt-in.

4. Patient sets the taskYesdocumented
Not independently replicated
Yes! Chat with Neatly any time about your health for neutral guidance and support. Source

Patient chooses recordings and questions. Operator has its own aims (cohort insights, optional trial recruitment, premium specialists), but these are not documented as steering the patient's task.

5. Patient can decline or stopYesdocumented
Not independently replicated
Conversation recordings (doctor-patient visits you choose to record). Source

Self-started: Q3 is yes and no care depends on using Neatly. Source is the Q3 source. Terms 11: 'You may stop using the service anytime.'

6. Patient sees the AI outputYesdocumented
Not independently replicated
Within minutes, you'll get a plain-language summary of what was discussed Source

App Store listing: 'Read the full transcript whenever you want'.

7. Patient can correct or challengeYesdocumented
Not independently replicated
If you find mistakes in the transcription or notes, contact us for help. Source

Privacy section 7. Contact is a chat widget or message form. No self-serve edit is documented.

8. Patient can get a copyNonot-documented
Not independently replicated
To make a request to access, delete, correct, or opt out, contact us at: Source

An 'access' request is mentioned for state-law rights, but no export, download or copy is documented. Sharing summaries with caregivers is described as a feature.

9. Patient can deleteYesdocumented
Not independently replicated
If you want something deleted, just ask us and we'll remove it within 30 days. Source

Closing the account deletes everything within 90 days.

10. Training or sale does not override patient choiceNodocumented
Not independently replicated
Use your data in de-identified or aggregated form for research and commercial purposes. Source

Terms section 4 license. No opt-out is offered for de-identified or aggregated use. FAQ says Neatly sells population insights to pharma. Training is not addressed. Identifiable sharing is opt-in only.

11. Patient can run it or take it elsewhereNonot-documented
Not independently replicated
Quotation not recorded; evidence repair pending. Source

Vendor-hosted. No self-hosting or documented move-elsewhere route.

12. No advertising or data businessNodocumented
Not independently replicated
We sell aggregated, de-identified insights to pharmaceutical and medical device companies. Source

FAQ: 'We make money by selling population-based insights to pharmaceutical companies and other research organizations'. Marketing says individual data is never sold, which is consistent with the Terms. Optional opportunities may also share identifiable data with pharma or CROs with consent.

Initial coding: Claude Sonnet helpers, compiled by Claude Opus 5.5 (Anthropic). Selective review and corrections: GPT-6 Astra (OpenAI). Editor: Hugo Campos. Acceptance of corrections is not product verification.

Checklist rules · Independent review and limitations · Later evidence follow-up

Earlier report

Neatly Health: CAIHL reassessment

September 8, 2026. Published AI-assisted draft.

Neatly supports patient-selected records and sharing. Optional identifiable sharing must be distinguished from population insights. The review corrects blanket sharing claims and outdated caregiver-feature descriptions, while keeping source and correction gaps explicit.

Scope and agency posture

Patient-initiated recording, summaries and health questions, with separate cohort-insight commercialization and optional third-party opportunities.

Posture: Potentially agency-expanding, with data-commercialization caveat.

Axis: 82/100, retained provisionally. No numerical recalibration was performed.

Sources and documented findings

  • The current FAQ describes recording and follow-up questions, acknowledges revenue from population insights, and claims sponsors do not control patient insights. It distinguishes current text/email sharing from forthcoming integrated caregiver features. https://www.neatlyhealth.ai/faq
  • The policy documents deletion requests within 30 days and account closure deletion within 90 days. Optional opportunities require consent, which can stop future sharing but cannot undo past transfers. Formal access/correction/opt-out requests depend on applicable rights. https://www.neatlyhealth.ai/privacy-policy

Patient authority

Inference from the documented workflow: Patients initiate recording and questions and can reuse summaries. The public pass does not establish editable transcripts or control over all cohort-derived uses.

Critical capacity

Editorial assessment: A retained visit account can support questions and challenge misunderstandings. Cohort patterns are not necessarily comparable treatment evidence, and per-answer source links remain unverified.

Informed control

Editorial assessment: The FAQ's blanket no-individual-sharing language needs the policy's explicit optional sharing exception. Sponsor non-influence is a vendor statement, not independently verified neutrality.

Assessment and limits

The positive but qualified posture remains defensible. Free use and deidentification do not remove competing data interests. Current versus planned caregiver functionality needs accurate wording.

Confidence: Moderate for public product and policy descriptions.

Remaining uncertainty: Transcript editing, source links, aggregate-use refusal and third-party processing specifics remain unresolved

Published documentation is evidence of stated conditions, not proof of actual implementation. Unknowns did not receive automatic negative points. Funding, sponsorship, and public code do not determine agency by themselves.

Review provenance

  • Reviewer/model: OpenAI Codex / GPT-6.
  • Method: Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
  • Human review: Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
  • Earlier review: 2026-06-28. Historical assessment. Earlier claims are not automatically reverified by this publication.